Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 19 » default
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4185)
- Volume 20, 2024 (79)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 19, 2023
- default (249)
- Beneath the surface: genetic factors in schizophrenia (2)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
- Family and Peer Facilitated/Led Interventions for Severe Mental Health Problems (2)
- Therapeutic Response to Psychedelic Therapy – Who, What, Why & How? (3)
- Suicide Prevention and Intervention: Recent Evidence and Future Directions (4)
- Autism, the disorder without borders and geopolitical variations (3)
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
Wang L, Chen X, Gu X, De Smedt H, Popova V, Fu DJ, Canuso CM, Drevets WC, Chen G
Neuropsychiatric Disease and Treatment 2023, 19:2857-2870
Published Date: 27 December 2023
Risk Factors Associated with Epilepsy Related to Cerebrovascular Disease: A Systematic Review and Meta-Analysis
Mafla-Mendoza AP, Paredes-Urbano ED, Gea-Izquierdo E
Neuropsychiatric Disease and Treatment 2023, 19:2841-2856
Published Date: 27 December 2023
Examining the Role of GLU/GABA to GLN Metabolic Cycle in the Pathogenesis of Post-Stroke Depressive Disorder and Insomnia
Zhang XH, Zhang X, Liu XW, Lai PH, Cao CC, Wang YL, Ren LJ
Neuropsychiatric Disease and Treatment 2023, 19:2833-2840
Published Date: 22 December 2023
Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights
Fagiolini A, González Pinto A, Miskowiak KW, Morgado P, Young AH, Vieta E
Neuropsychiatric Disease and Treatment 2023, 19:2817-2831
Published Date: 21 December 2023
The Interaction of LAMA2 and Duration of Illness Affects the Thickness of the Right Transverse Temporal Gyrus in Major Depressive Disorder
Chen G, Li L, Sun T, Jiang C, Xu W, Chen S, Hu C, Yue Y, Wang T, Jiang W, Yuan Y
Neuropsychiatric Disease and Treatment 2023, 19:2807-2816
Published Date: 20 December 2023
Functional Alterations in Patients with Bipolar Disorder and Their Unaffected First-Degree Relatives: Insight from Genetic, Epidemiological, and Neuroimaging Data
Zhang H, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:2797-2806
Published Date: 14 December 2023
A Linear Regression Equation for Predicting the Residual Volume of Chronic Subdural Hematoma 1 Week After Surgery
Yan C, Su C, Ye YF, Liu J
Neuropsychiatric Disease and Treatment 2023, 19:2787-2796
Published Date: 14 December 2023
Regional Homogeneity of the Left Posterior Cingulate Gyrus May Be a Potential Imaging Biomarker of Manic Episodes in First-Episode, Drug-Naive Bipolar Disorder
Wu J, Qi S, Yu W, Gao Y, Ma J
Neuropsychiatric Disease and Treatment 2023, 19:2775-2785
Published Date: 12 December 2023
Prediction of Acute Kidney Injury in Intracerebral Hemorrhage Patients Using Machine Learning
She S, Shen Y, Luo K, Zhang X, Luo C
Neuropsychiatric Disease and Treatment 2023, 19:2765-2773
Published Date: 11 December 2023
It Goes Beyond Anxiety: Experiences of Family Members and Caregivers of Epilepsy Care and Support
Musekwa OP, Makhado L
Neuropsychiatric Disease and Treatment 2023, 19:2757-2764
Published Date: 7 December 2023
Dynamic Nomogram for Subsyndromal Delirium in Adult Intensive Care Unit: A Prospective Cohort Study [Corrigendum]
Cheng J, Lao Y, Chen X, Qiao X, Sui W, Gong X, Zhuang Y
Neuropsychiatric Disease and Treatment 2023, 19:2755-2756
Published Date: 7 December 2023
Microvascular Changes in Pituitary Adenoma Correlate with Structural Measurements and Visual Field Loss
Chen Y, Li X, Song X, Cong L, Zhang Y
Neuropsychiatric Disease and Treatment 2023, 19:2745-2754
Published Date: 6 December 2023
Peripheral and Central Nervous System Biomarkers of Inflammation in Functional Seizures: Assessment with Magnetic Resonance Spectroscopy
Mueller C, Sharma AA, Szaflarski JP
Neuropsychiatric Disease and Treatment 2023, 19:2729-2743
Published Date: 5 December 2023
Serum Secreted Protein Acidic and Rich in Cysteine-Like 1 as a Biochemical Predictor for Prognosticating Clinical Outcomes After Acute Supratentorial Intracerebral Hemorrhage: A Prospective Cohort Study
Huang J, Shao F, Chen B, Zheng G, Shen J, Qiu S
Neuropsychiatric Disease and Treatment 2023, 19:2709-2728
Published Date: 5 December 2023
Acute Phase Blood Glucose Levels and Functional Outcomes in Patients with Spontaneous Intracerebral Hemorrhage
Zhou Y, Luo Z, Yu M, Zhan C, Xu H, Lin R, Bian S, Yang Y, Jiang Z, Tao X, Ye Z, Wang M, Zhu D
Neuropsychiatric Disease and Treatment 2023, 19:2697-2707
Published Date: 5 December 2023
Ferulic Acid Activates SIRT1-Mediated Ferroptosis Signaling Pathway to Improve Cognition Dysfunction in Wilson’s Disease
Wang X, Shao N, Zhang X, Chen H, Chang Z, Xie D, Zhang J
Neuropsychiatric Disease and Treatment 2023, 19:2681-2696
Published Date: 5 December 2023
Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes
Antonov A, Terraciano A, Essibayi MA, Javed K, Altschul DJ
Neuropsychiatric Disease and Treatment 2023, 19:2673-2680
Published Date: 5 December 2023
Electroacupuncture Ameliorates Depression-Like Behaviors in Post-Stroke Rats via Activating AMPK-Mediated Mitochondrial Function
Ding Z, Gao J, Feng Y, Wang M, Zhao H, Wu R, Zheng X, Feng X, Lai M
Neuropsychiatric Disease and Treatment 2023, 19:2657-2671
Published Date: 4 December 2023
Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence
Vu T, Wiendl H, Katsuno M, Reddel SW, Howard JF Jr
Neuropsychiatric Disease and Treatment 2023, 19:2639-2655
Published Date: 1 December 2023
Real-Time Hemodynamic Changes in the Prefrontal and Bilateral Temporal Cortices During Intradermal Acupuncture for Major Depressive Disorder: A Prospective, Single-Center, Controlled Trial Protocol
Xiong S, Tu M, Wu X, Qu S, Chen N, Jin J, Rong H, Pei S, Fang J, Shao X
Neuropsychiatric Disease and Treatment 2023, 19:2627-2638
Published Date: 1 December 2023
Polygenic Risk Scores for Bipolar Disorder: Progress and Perspectives
Liu H, Wang L, Yu H, Chen J, Sun P
Neuropsychiatric Disease and Treatment 2023, 19:2617-2626
Published Date: 29 November 2023
Association Between Migraine and Gastrointestinal Disease in Pediatric Patients: A Propensity Score Weighting Approach
Rhew K
Neuropsychiatric Disease and Treatment 2023, 19:2607-2615
Published Date: 28 November 2023
Evidence-Supported Interventions for Reducing Secondary Stroke Risk in Sub-Saharan Africa: A Systematic Review
Kaddumukasa M, Edwards AM, Najjuma JN, Mbalinda SN, Nakibuuka J, Burant CJ, Moore SM, Blixen C, Katabira ET, Sajatovic M, Kaddumukasa M
Neuropsychiatric Disease and Treatment 2023, 19:2597-2606
Published Date: 28 November 2023
Lymphocyte to Monocyte Ratio is Independently Associated with Futile Recanalization in Acute Ischemic Stroke After Endovascular Therapy
Guan J, Wang Q, Zhao Q
Neuropsychiatric Disease and Treatment 2023, 19:2585-2596
Published Date: 28 November 2023
Anxiety as a Risk Factor for Acute Mountain Sickness Among Young Chinese Men After Exposure at 3800 M: A cross‒sectional Study
Tang X, Li X, Xin Q, Wang Q, Li S, Yang Y
Neuropsychiatric Disease and Treatment 2023, 19:2573-2583
Published Date: 28 November 2023
NR3C1 and NR3C2 Genes Increase the Risk of Suicide Attempt in Psychiatric Disorder Patients with History of Childhood Trauma
Sanabrais-Jiménez MA, Esquivel-López AA, Sotelo-Ramírez CE, Aguilar-García A, Ordoñez-Martínez B, Jiménez-Pavón J, Madrigal-Lara MV, Díaz-Vivanco AJ, Camarena B
Neuropsychiatric Disease and Treatment 2023, 19:2561-2571
Published Date: 24 November 2023
Neural Correlates of Anhedonia in Major Depressive Disorder: Insights from Concurrent Analysis of Feedback-Related Negativity and Stimulus-Preceding Negativity
Sun Y, Huang Z, Gao X, Chen L, Wang J, Zhou Z, Zhou H
Neuropsychiatric Disease and Treatment 2023, 19:2549-2560
Published Date: 23 November 2023
Dynamic Nomogram for Subsyndromal Delirium in Adult Intensive Care Unit: A Prospective Cohort Study
Cheng J, Lao Y, Chen X, Qiao X, Sui W, Gong X, Zhuang Y
Neuropsychiatric Disease and Treatment 2023, 19:2535-2548
Published Date: 22 November 2023
Gene Polymorphisms and Expression of NRG1, DAOA, and DISC1 Genes in a Chinese Han Population with an Ultra-High Risk for Psychosis
He XY, Huang ZH, Wang F, Chen ZL, Wang SB, Jia FJ, Hou CL
Neuropsychiatric Disease and Treatment 2023, 19:2521-2533
Published Date: 21 November 2023
Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]
Yang Q, Wang J, Mi N, Zou Y
Neuropsychiatric Disease and Treatment 2023, 19:2519-2520
Published Date: 21 November 2023
Association Between Maternal Mood Disorders and Schizophrenia and the Risk of Type 1 Diabetes in Offspring: A Nationwide Cohort Study
Liu YC, Liao YT, Chen VCH, Chen YL
Neuropsychiatric Disease and Treatment 2023, 19:2511-2518
Published Date: 20 November 2023
Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X, Wang L, Li S
Neuropsychiatric Disease and Treatment 2023, 19:2499-2509
Published Date: 20 November 2023
Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article
Zimek D, Miklusova M, Mares J
Neuropsychiatric Disease and Treatment 2023, 19:2485-2497
Published Date: 20 November 2023
Narrative Review: Pathogenesis of the Inflammatory Response and Intestinal Flora in Depression
Zeng JW, Zhao JL, Han ZJ, Duan YJ, Lin L
Neuropsychiatric Disease and Treatment 2023, 19:2469-2483
Published Date: 16 November 2023
Frozen in Time, a Focused Review of Autism Prevalence in Canadian Indigenous Communities
Hus Y
Neuropsychiatric Disease and Treatment 2023, 19:2451-2468
Published Date: 16 November 2023
The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia
Zhu X, Wen M, He Y, Feng J, Xu X, Liu J
Neuropsychiatric Disease and Treatment 2023, 19:2439-2450
Published Date: 15 November 2023
qEEG as Biomarker for Alzheimer’s Disease: Investigating Relative PSD Difference and Coherence Analysis
Simfukwe C, Han SH, Jeong HT, Youn YC
Neuropsychiatric Disease and Treatment 2023, 19:2423-2437
Published Date: 9 November 2023
Peripheral Blood Th1/Th17 Immune Cell Shift is Associated with Disease Activity and Severity of AQP4 Antibody Sero-Positive Neuromyelitis Optica Spectrum Disorder
Cao F, Wang Y, Wei R, Li C, Cheng Y, Zhou Y, Jin T, Zhang H, Lin L, Xu B
Neuropsychiatric Disease and Treatment 2023, 19:2413-2421
Published Date: 9 November 2023
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population
Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Åström DO, Christensen MC
Neuropsychiatric Disease and Treatment 2023, 19:2401-2412
Published Date: 8 November 2023
A Meta-Analysis on the Efficacy of Acupuncture as an Adjuvant Therapy for Schizophrenia
Huang C, Zhang P, Dong Y, Chang R, Lao J, Li Z, Lan D
Neuropsychiatric Disease and Treatment 2023, 19:2381-2400
Published Date: 7 November 2023
A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage
Shentu HS, Chen YH, Cheng ZY, Fu B, Fu YH, Zheng SF, Li C
Neuropsychiatric Disease and Treatment 2023, 19:2363-2379
Published Date: 6 November 2023
Toll-Like Receptor (TLR) 1, 2, and 6 Gene Polymorphisms Support Evidence of Innate Immune Factors in Schizophrenia
Sotelo-Ramírez CE, Camarena B, Sanabrais-Jiménez MA, Zaragoza-Hoyos JU, Ordoñez-Martínez B, Escamilla-Orozco RI, Gómez-González B
Neuropsychiatric Disease and Treatment 2023, 19:2353-2361
Published Date: 2 November 2023
Multidimensional Outcomes of IV Thrombolysis in Minor Ischemic Stroke: Motor, Psychocognitive, and Dependence
Li N, Zhang J, Li SJ, Du Y, Zhou Q, Gu HQ, Zhao XQ
Neuropsychiatric Disease and Treatment 2023, 19:2341-2351
Published Date: 1 November 2023
Comparison of Short-Term Surgery Outcomes and Clinical Characteristics Between Elderly and Non-Elderly Patients with Middle Third Parasagittal and Parafalcine Meningiomas
Chen Z, Lin T, Liu D, Zeng Y, Zhang X, Deng B, Guo D, Shi T, Lu M
Neuropsychiatric Disease and Treatment 2023, 19:2331-2340
Published Date: 30 October 2023
miR-98-5p Prevents Hippocampal Neurons from Oxidative Stress and Apoptosis by Targeting STAT3 in Epilepsy in vitro
Guo Z, Zhong W, Zou Z
Neuropsychiatric Disease and Treatment 2023, 19:2319-2329
Published Date: 30 October 2023
Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia
Zhan L, Yin H, Gao Y, Li Y, Ma J
Neuropsychiatric Disease and Treatment 2023, 19:2309-2318
Published Date: 27 October 2023
Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis
Peng Z, Jia Q, Mao J, Yi Q
Neuropsychiatric Disease and Treatment 2023, 19:2295-2308
Published Date: 26 October 2023
Associations Between the Suicidal Ideation and the Tolerance for Psychological Pain and Tolerance for Physical Pain in Patients Diagnosed with Major Depressive Disorder
Yeşiloğlu C, Tamam L, Demirkol ME, Namlı Z, Karaytuğ MO
Neuropsychiatric Disease and Treatment 2023, 19:2283-2294
Published Date: 25 October 2023
Relationship Between Childhood Trauma and Nonsuicidal Self-Injury Among Adolescents with Depressive Disorder: Mediated by Negative Life Events and Coping Style
Xie X, Liu J, Gong X, Sun T, Li Y, Liu Z, Yang BX, Zhang L, Zhu K, Cai Z
Neuropsychiatric Disease and Treatment 2023, 19:2271-2281
Published Date: 25 October 2023
Neurocognitive Characteristics of Subjective Cognitive Decline and Its Association with Objective Cognition, Negative Emotion, and Sleep Quality in Chinese Elderly
Wu Y, Mao Z, Cui F, Fan J, Yuan Z, Tang L
Neuropsychiatric Disease and Treatment 2023, 19:2261-2270
Published Date: 25 October 2023
The Predictive Value of Essen and SPI-II on the Risk of 5-Year Recurrence in Chinese Patients with Acute Ischemic Stroke
Zhao J, Wang D, Liu X, Wang Y, Zhao X
Neuropsychiatric Disease and Treatment 2023, 19:2251-2260
Published Date: 24 October 2023
The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression
Gao M, Sang W, Mi K, Liu J, Liu Y, Zhen W, An B
Neuropsychiatric Disease and Treatment 2023, 19:2241-2249
Published Date: 24 October 2023
Heart Rate Variability in Psychiatric Disorders: A Systematic Review
Ramesh A, Nayak T, Beestrum M, Quer G, Pandit JA
Neuropsychiatric Disease and Treatment 2023, 19:2217-2239
Published Date: 20 October 2023
Establishing Patient-Centered Outcomes for MCT8 Deficiency: Stakeholder Engagement and Systematic Literature Review
Wilpert NM, Tonduti D, Vaia Y, Krude H, Sarret C, Schuelke M
Neuropsychiatric Disease and Treatment 2023, 19:2195-2216
Published Date: 20 October 2023
Promoting Meaning and Recovery for Psychosis: Comparison of Metacognitively-Oriented Psychotherapists and Clinicians in Psychiatric Rehabilitation
Faith L, Wiesepape C, Kukla M, Lysaker P
Neuropsychiatric Disease and Treatment 2023, 19:2179-2194
Published Date: 18 October 2023
Glial Fibrillary Acidic Protein Levels in Post-Stroke Depression: A Prospective Ischemic Stroke Cohort
Shan W, Zhao J, Qiu C, Xu G, Feng J
Neuropsychiatric Disease and Treatment 2023, 19:2171-2178
Published Date: 18 October 2023
Subthreshold Depression: A Systematic Review and Network Meta-Analysis of Non-Pharmacological Interventions
Hao X, Jia Y, Chen J, Zou C, Jiang C
Neuropsychiatric Disease and Treatment 2023, 19:2149-2169
Published Date: 16 October 2023
Levels of IL-6 are Associated with Lifetime Attempted Suicide in Alcohol Use Disorder Patients
Bramness JG, Pandey S, Moe JS, Toft H, Lien L, Walby FA, Myhre MØ, Bolstad I
Neuropsychiatric Disease and Treatment 2023, 19:2141-2148
Published Date: 12 October 2023
Inhibition of SK Channels in VTA Affects Dopaminergic Neurons to Improve the Depression-Like Behaviors of Post-Stroke Depression Rats
Wang A, Zhou Y, Chen H, Jin J, Mao Y, Tao S, Qiu T
Neuropsychiatric Disease and Treatment 2023, 19:2127-2139
Published Date: 9 October 2023
Understanding Patients’ Experiences with Borderline Personality Disorder: Qualitative Interviews
DiBenedetti D, Kosa K, Waters HC, Oberdhan D
Neuropsychiatric Disease and Treatment 2023, 19:2115-2125
Published Date: 9 October 2023
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis
Ko K, Carter B, Cleare AJ, Rucker JJ
Neuropsychiatric Disease and Treatment 2023, 19:2105-2113
Published Date: 5 October 2023
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety
Fernández-Miranda JJ, Díaz-Fernández S
Neuropsychiatric Disease and Treatment 2023, 19:2093-2103
Published Date: 5 October 2023
The Association of Nocturnal Seizures and Interictal Cardiac/Central Autonomic Function in Frontal Lobe Epilepsy: Heart Rate Variability and Central Autonomic Network Analysis
Kim W, Lee H, Lee KW, Yang E, Kim S
Neuropsychiatric Disease and Treatment 2023, 19:2081-2091
Published Date: 3 October 2023
Frequency and Characteristics of Depression and Its Association with Diminished Quality of Life in a Cohort of Individuals with Post-Acute Sequelae of COVID-19
Shahar S, Lynch S, Dornbush R, Klepacz L, Smiley A, Ferrando SJ
Neuropsychiatric Disease and Treatment 2023, 19:2069-2079
Published Date: 3 October 2023
Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population
Iwata M, Hatano M, Ito K, Matsuzaki H, Yamada S
Neuropsychiatric Disease and Treatment 2023, 19:2061-2068
Published Date: 2 October 2023
Frequency and Risk Factors of Subsyndromal Delirium in the Intensive Care Units: A Prospective Cohort Study [Corrigendum]
Gao Y, Gong S, Zhou W, Li X, Gan X
Neuropsychiatric Disease and Treatment 2023, 19:2057-2059
Published Date: 29 September 2023
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
Ye J, Zhang T
Neuropsychiatric Disease and Treatment 2023, 19:2055-2056
Published Date: 28 September 2023
Neurocognitive Recovery in Abstinent Patients with Alcohol Use Disorder: A Scoping Review for Associated Factors
Staudt J, Kok T, de Haan HA, Walvoort SJW, Egger JIM
Neuropsychiatric Disease and Treatment 2023, 19:2039-2054
Published Date: 28 September 2023
Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder
Xu H, Zheng L, Wang L, Gao H, Wei Y, Chen J
Neuropsychiatric Disease and Treatment 2023, 19:2027-2037
Published Date: 28 September 2023
Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
Dini G, Di Cara G, Ferrara P, Striano P, Verrotti A
Neuropsychiatric Disease and Treatment 2023, 19:2013-2025
Published Date: 26 September 2023
Considerations When Using Gabapentinoids to Treat Trigeminal Neuralgia: A Review
De Stefano G, Di Pietro G, Truini A, Cruccu G, Di Stefano G
Neuropsychiatric Disease and Treatment 2023, 19:2007-2012
Published Date: 19 September 2023
Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review
Ma N, Zhang L, Zhang W, He Y, Ye C, Li X
Neuropsychiatric Disease and Treatment 2023, 19:1987-2006
Published Date: 18 September 2023
Neurological Manifestations of Long COVID: A Single-Center One-Year Experience [Response to Letter]
Taruffi L, Muccioli L, Bisulli F
Neuropsychiatric Disease and Treatment 2023, 19:1985-1986
Published Date: 18 September 2023
Investigation on Awareness of Cognitive Impairment Diseases Among Surgical Practitioners
Hao Y, Yang X, Ma W, Zhang X, Wang Y, Qian S
Neuropsychiatric Disease and Treatment 2023, 19:1973-1984
Published Date: 15 September 2023
Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease
Constantin VA, Szász JA, Dulamea AO, Valkovic P, Kulisevsky J
Neuropsychiatric Disease and Treatment 2023, 19:1959-1972
Published Date: 14 September 2023
Activation Map Reveals Language Impairment in Children with Benign Epilepsy with Centrotemporal Spikes (BECTS)
Mo T, Huang W, Sun W, Hu Y, Mcdonald L, Hu Z, Chen L, Liao J, Hermann B, Prabhakaran V, Zeng H
Neuropsychiatric Disease and Treatment 2023, 19:1949-1957
Published Date: 13 September 2023
Oligodendrocyte Progenitor Cell Transplantation Ameliorates Preterm Infant Cerebral White Matter Injury in Rats Model
Wang Z, Zhang L, Yang Y, Wang Q, Qu S, Wang X, He Z, Luan Z
Neuropsychiatric Disease and Treatment 2023, 19:1935-1947
Published Date: 11 September 2023
Altered Functional Connectivity of Large-Scale Brain Networks in Psychogenic Erectile Dysfunction Associated with Cognitive Impairments
Feng S, Dong L, Yan B, Zheng S, Feng Z, Li X, Li J, Sun N, Ning Y, Jia H
Neuropsychiatric Disease and Treatment 2023, 19:1925-1933
Published Date: 5 September 2023
Factors Influencing Long-Term Behavioral Intervention Outcomes in Preschool Children with Attention-Deficit Hyperactivity Disorder in Southeast China
Huang X, Qian Q, Huang Y, Wang Y, Ou P
Neuropsychiatric Disease and Treatment 2023, 19:1911-1923
Published Date: 4 September 2023
Path Analysis of Self-Efficacy, Coping Style and Resilience on Depression in Patients with Recurrent Schizophrenia
Wang L, Li M, Guan B, Zeng L, Li X, Jiang X
Neuropsychiatric Disease and Treatment 2023, 19:1901-1910
Published Date: 1 September 2023
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
Lienggonegoro LA, Dany F, Panjaitan NSD
Neuropsychiatric Disease and Treatment 2023, 19:1899-1900
Published Date: 1 September 2023
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study
Chiappini S, Di Carlo F, Mosca A, d'Andrea G, Di Paolo M, Lorenzini C, Lupica MG, Sampogna G, Pettorruso M, Fiorillo A, Martinotti G
Neuropsychiatric Disease and Treatment 2023, 19:1887-1897
Published Date: 30 August 2023
Acupuncture and Tuina Treatment for Gross Motor Function in Children with Spastic Cerebral Palsy: A Monocentric Clinical Study
Wang X, Teh SH, Du XG, Wang XH
Neuropsychiatric Disease and Treatment 2023, 19:1875-1886
Published Date: 30 August 2023
Increased Serum S100β Concentration is Associated with Depression in Parkinson’s Disease
Jiang G, Sheng C, Yan L, Wang Z, Wang Q, Chen R, Zhao Y
Neuropsychiatric Disease and Treatment 2023, 19:1865-1873
Published Date: 28 August 2023
The Morbidity and Associated Factors of Depression in Caregivers of Patients with Depressive Disorder
Lee Y, Lin PY, Huang YC, Chiu NM, Hung CF, Wang LJ
Neuropsychiatric Disease and Treatment 2023, 19:1853-1864
Published Date: 24 August 2023
Advancements in Transcranial Magnetic Stimulation Research and the Path to Precision
Sun W, Wu Q, Gao L, Zheng Z, Xiang H, Yang K, Yu B, Yao J
Neuropsychiatric Disease and Treatment 2023, 19:1841-1851
Published Date: 23 August 2023
Ruptured Anterior Communicating Artery Aneurysms Concomitant with Small Intracranial Hematoma: Evacuating Hematoma or Not?
Cai J, He C, Xu J, He Q, Su J, Wu Z, Xu Y
Neuropsychiatric Disease and Treatment 2023, 19:1833-1840
Published Date: 23 August 2023
Optimizing Treatment for Major Depressive Disorder in Adolescents: The Impact of Intradermal Acupuncture - A Randomized Controlled Trial Protocol
Chen N, Wu X, Tu M, Xiong S, Jin J, Qu S, Pei S, Fang J, Shao X
Neuropsychiatric Disease and Treatment 2023, 19:1819-1832
Published Date: 23 August 2023
Incidence and Factors Associated with Hyperglycemia in Patients with First Hospitalization for Major Depression Disorder: A Large Cross-Sectional Sample
Qi S, Xu Y, Zeng K, Li Y, Ma J
Neuropsychiatric Disease and Treatment 2023, 19:1809-1818
Published Date: 21 August 2023
The Neural Correlates of the Social Perception Dysfunction in Schizophrenia: An fMRI Study
Gao X, Huang Z, Li J, Zhou Z, Zhou H
Neuropsychiatric Disease and Treatment 2023, 19:1799-1808
Published Date: 21 August 2023
Parkinson’s Disease and Subjective Prospects for the Future in Different Life Domains. Findings of a Nationally Representative Sample
Hajek A, Grupp K, Aarabi G, Kretzler B, König HH
Neuropsychiatric Disease and Treatment 2023, 19:1791-1798
Published Date: 16 August 2023
Investigation of Altered Spontaneous Brain Activity Patterns in Herpes Zoster Keratitis Using the Percent Amplitude of Fluctuation Method: A Resting-State Functional Magnetic Resonance Imaging Study
Liao X, Li CQ, Ge QM, Tang LY, Su T, Li QY, Pan YC, Shu HY, Zhang LJ, Shao Y
Neuropsychiatric Disease and Treatment 2023, 19:1781-1789
Published Date: 15 August 2023
A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation
Al-Ayadhi L, Abualnaja A, AlZarroug A, Alharbi T, Alhowikan AM, Halepoto DM, Al-Mazidi S
Neuropsychiatric Disease and Treatment 2023, 19:1771-1780
Published Date: 14 August 2023
Electroconvulsive Therapy Reduces Protein Expression Level of EP300 and Improves Psychiatric Symptoms and Disturbance of Thought in Patients with Schizophrenia
Peng W, Wang S, Yu M, Wang T, He R, Liu D, Chen D, Liang X, Liu K, Xiang B
Neuropsychiatric Disease and Treatment 2023, 19:1763-1770
Published Date: 2 August 2023
Analysis of Factors Correlated with Postoperative Kinesiophobia in Patients with Cervical Spondylotic Myelopathy: A Cross-Sectional Survey
Zhong GQ, Lin BH, Chen YX, Lin YJ, Chen CM
Neuropsychiatric Disease and Treatment 2023, 19:1755-1761
Published Date: 2 August 2023
Targeting Mitochondrial Homeostasis: The Role of Acupuncture in Depression Treatment
Chen H, Wu C, Lv Q, Li M, Ren L
Neuropsychiatric Disease and Treatment 2023, 19:1741-1753
Published Date: 1 August 2023
Effects of Music, Massage, Exercise, or Acupuncture in the Treatment of Depression Among College Students: A Network Meta-Analysis
Li FB, Lu P, Wu HT, Wang MH, Wang JD
Neuropsychiatric Disease and Treatment 2023, 19:1725-1739
Published Date: 1 August 2023
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study
Ye J, Wei Y, Zeng J, Gao Y, Tang X, Xu L, Hu Y, Liu X, Liu H, Chen T, Li C, Zeng L, Wang J, Zhang T
Neuropsychiatric Disease and Treatment 2023, 19:1711-1723
Published Date: 31 July 2023
Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter]
Rege B, Meyer JM
Neuropsychiatric Disease and Treatment 2023, 19:1709-1710
Published Date: 31 July 2023
Immediate Effects of Mobile Phone App for Depressed Mood in Young Adults with Subthreshold Depression: A Pilot Randomized Controlled Trial
Ejiri H, Uchida H, Tsuchiya K, Fujiwara K, Kikuchi S, Hirao K
Neuropsychiatric Disease and Treatment 2023, 19:1695-1707
Published Date: 31 July 2023
Magnetic Resonance Imaging Characteristics of Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: A Pediatric Series in Southwest China
Cheng W, He L, Luo H, Jiang Y, Tan C, Fan X
Neuropsychiatric Disease and Treatment 2023, 19:1685-1693
Published Date: 29 July 2023
Depressive Symptoms and Its Associated Factors Among Primary Caregivers of Stroke Survivors at Amhara Regional State Tertiary Hospitals: Multicenter Study
Eriku GA, Bekele G, Yitayal MM, Belete Y, Girma Y
Neuropsychiatric Disease and Treatment 2023, 19:1675-1684
Published Date: 28 July 2023
Correlation Analyses Between Childhood Behavioral Disturbance and Maternal Alexithymia: An Observational Study
Lin YC, Lee WY
Neuropsychiatric Disease and Treatment 2023, 19:1665-1674
Published Date: 28 July 2023
Sydenham Chorea in Sudan; Presentation Panorama
A Ibrahim EA, Mohamed RH, Abbasher Hussien Mohamed Ahmed K, AbdAlla Mohamed MT, Fadelallah Eljack MM
Neuropsychiatric Disease and Treatment 2023, 19:1657-1663
Published Date: 26 July 2023
Commentary on “Frequency and Risk Factors of Subsyndromal Delirium in the Intensive Care Units: A Prospective Cohort Study” by Gao et al [Letter]
Wake AD
Neuropsychiatric Disease and Treatment 2023, 19:1655-1656
Published Date: 25 July 2023
Development and Validation of a Delirium Risk Prediction Model for Elderly Patients Undergoing Elective Orthopedic Surgery
Guo Y, Ji H, Liu J, Wang Y, Liu J, Sun H, Fei Y, Wang C, Ma T, Han C
Neuropsychiatric Disease and Treatment 2023, 19:1641-1654
Published Date: 21 July 2023
Research Progress on Psychological Distress in Patients with Ectopic Pregnancy in China
Ren N, Dela Rosa RD, Chen Z, Gao Y, Chang L, Li M, Peng D
Neuropsychiatric Disease and Treatment 2023, 19:1633-1639
Published Date: 21 July 2023
The Protective Role and Mechanism of Mild Therapeutic Hypothermia Protection on Brain Cells
Liang S, Ti Y, Li X, Zhou W
Neuropsychiatric Disease and Treatment 2023, 19:1625-1631
Published Date: 17 July 2023
Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Response to Letter]
Chen CC, Wang XB
Neuropsychiatric Disease and Treatment 2023, 19:1623-1624
Published Date: 17 July 2023
Benefits of Working from Home During the COVID-19 Pandemic for Undiagnosed Workers with Attention-Deficit/Hyperactivity Disorder Symptoms
Ishimoto Y, Sotodate T, Namba Y, Uenishi T, Iwasaki K, Tomita H
Neuropsychiatric Disease and Treatment 2023, 19:1607-1621
Published Date: 15 July 2023
Neurological manifestations of long COVID: a single-center one-year experience [Letter]
Li X, Hu H, Cheng Y
Neuropsychiatric Disease and Treatment 2023, 19:1605-1606
Published Date: 14 July 2023
Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study
Zhu X, Li R, Zhu Y, Zhou J, Huang J, Zhou Y, Tong J, Zhang P, Luo X, Chen S, Li Y, Tian B, Tan SP, Wang Z, Han X, Tian L, Li CSR, Tan YL
Neuropsychiatric Disease and Treatment 2023, 19:1597-1604
Published Date: 12 July 2023
Identifying Poor Prognostic Factors in Patients with Cerebral Venous Sinus Thrombosis: A Clinical Analysis for Prompt Patient Management [Letter]
Asif M, Siddiqui T
Neuropsychiatric Disease and Treatment 2023, 19:1595-1596
Published Date: 12 July 2023
Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Letter]
Manu L
Neuropsychiatric Disease and Treatment 2023, 19:1593-1594
Published Date: 12 July 2023
Effects of Electroacupuncture on Gut Microbiota and Fecal Metabolites in Rats with Poststroke Depression
Cai W, Wei XF, Hu C, Ji J, Cui HS, Shen WD
Neuropsychiatric Disease and Treatment 2023, 19:1581-1592
Published Date: 12 July 2023
White Matter Structural Connectivity and Its Impact on Psychogenic Non-Epileptic Seizures: An Evidence-Based Review
Sone D
Neuropsychiatric Disease and Treatment 2023, 19:1573-1579
Published Date: 11 July 2023
The Correlation Between Night Shift Work Schedules, Sleep Quality, and Depression Symptoms
Alreshidi SM, Rayani AM
Neuropsychiatric Disease and Treatment 2023, 19:1565-1571
Published Date: 7 July 2023
Metabolic Alterations and Related Biological Functions of Post-Stroke Depression in Ischemic Stroke Patients
Wen L, Yan C, Zheng W, Li Y, Wang Y, Qu M
Neuropsychiatric Disease and Treatment 2023, 19:1555-1564
Published Date: 6 July 2023
Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
Zuo L, Dong Y, Pan Y, Yan H, Meng X, Li H, Zhao X, Wang Y, Wang Y, Liao X
Neuropsychiatric Disease and Treatment 2023, 19:1543-1554
Published Date: 5 July 2023
Ru360 Alleviates Postoperative Cognitive Dysfunction in Aged Mice by Inhibiting MCU-Mediated Mitochondrial Dysfunction
Xu X, Zhou B, Liu J, Ma Q, Zhang T, Wu X
Neuropsychiatric Disease and Treatment 2023, 19:1531-1542
Published Date: 4 July 2023
The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders
Ye X, Zhou Q, Ren P, Xiang W, Xiao L
Neuropsychiatric Disease and Treatment 2023, 19:1515-1530
Published Date: 3 July 2023
Scientific Evidence of Acupuncture for Post-Stroke Cognitive Impairment: An Overview of Systematic Reviews and Meta-Analyses
Zhou Q, Ji Y, Lv Y, Xue J, Wang Y, Huang Y
Neuropsychiatric Disease and Treatment 2023, 19:1503-1513
Published Date: 3 July 2023
The Role of ElastPQ in Assessing Liver Stiffness for Non-Alcoholic Fatty Liver Disease in Patients Treated with Atypical Antipsychotic Drugs
Sun L, Li N, Zhang L, Chen J
Neuropsychiatric Disease and Treatment 2023, 19:1491-1502
Published Date: 30 June 2023
Parkinson’s Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022)
Zhang T, Yang R, Pan J, Huang S
Neuropsychiatric Disease and Treatment 2023, 19:1477-1489
Published Date: 29 June 2023
Declined Serum Resolvin D1 Levels to Predict Severity and Prognosis of Human Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
Yu D, Jiang F, Xu W, He P, Chen F, Liu X, Bao X
Neuropsychiatric Disease and Treatment 2023, 19:1463-1476
Published Date: 27 June 2023
Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
Cao Y, Xu Y, Xia Q, Shan F, Liang J
Neuropsychiatric Disease and Treatment 2023, 19:1455-1462
Published Date: 23 June 2023
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR16) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial
Trombello JM, Kulikova A, Mayes TL, Nandy K, Carmody T, Bart G, Nunes EV, Schmitz J, Kalmin M, Shoptaw S, Trivedi MH
Neuropsychiatric Disease and Treatment 2023, 19:1443-1454
Published Date: 22 June 2023
Association of Homocysteine with Acute Stroke and Its Subtypes in the Chinese Population
Zhang P, Zhang Y
Neuropsychiatric Disease and Treatment 2023, 19:1435-1442
Published Date: 15 June 2023
Effect of Continuation-Maintenance Electroconvulsive Therapy on Hospitalization: A Retrospective Mirror-Image Study
Sombatcharoen-non N, Yamnim T, Jullagate S, Ittasakul P
Neuropsychiatric Disease and Treatment 2023, 19:1427-1433
Published Date: 15 June 2023
Characteristics of Poor Prognosis in Patients with Cerebral Venous Sinus Thrombosis: A Multicenter Retrospective Study
Zhang Y, Liu Y, Qin B, Tang S, Liang Z
Neuropsychiatric Disease and Treatment 2023, 19:1417-1426
Published Date: 13 June 2023
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison
Harlin M, Chepke C, Larsen F, Bell Lynum KS, Chumki SR, Fitzgerald H, Such P, Madera-McDonough J, Yildirim M, Panni M, Saklad SR
Neuropsychiatric Disease and Treatment 2023, 19:1409-1416
Published Date: 8 June 2023
VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
Zheng C, Mao C, Tang K, Shu H
Neuropsychiatric Disease and Treatment 2023, 19:1397-1408
Published Date: 3 June 2023
A Systematic Review of the Relationship Between Neurodiversity and Psychosexual Functioning in Individuals with Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD)
Young S, Cocallis K
Neuropsychiatric Disease and Treatment 2023, 19:1379-1395
Published Date: 2 June 2023
Survey of Health Literacy Among Japanese Outpatients with Mental Illness
Sato Y, Sugawara N, Kawamata Y, Shimoda K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2023, 19:1369-1378
Published Date: 2 June 2023
Investigation for Anxiety and Depression Situation in Couples Receiving in vitro Fertilization and Embryo Transfer (IVF-ET) with Donor Sperm and Associated Influencing Factors
Liu X, Zhong E, Li J, Huang C, Liu W, Zeng L, Song G, Jiang R, Liu Y
Neuropsychiatric Disease and Treatment 2023, 19:1359-1367
Published Date: 2 June 2023
Leonurine Alleviates Cognitive Dysfunction and Reduces Oxidative Stress by Activating Nrf-2 Pathway in Alzheimer’s Disease Mouse Model
Xie Y, Jin Y, Li S, Shen B, Ma L, Zuo L, Gao Y, Yang G
Neuropsychiatric Disease and Treatment 2023, 19:1347-1357
Published Date: 1 June 2023
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia [Podcast]
Racher M, Carpenter W, Kane JM
Neuropsychiatric Disease and Treatment 2023, 19:1339-1345
Published Date: 2 June 2023
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]
Larrauri CA, Harvey PD, Kane JM
Neuropsychiatric Disease and Treatment 2023, 19:1331-1338
Published Date: 2 June 2023
Spontaneous Changes in Attentional Capabilities and Reasoning After an Alcohol Rehabilitation Treatment: Evidence About the Role of Age and Alcohol Use
Fiabane E, Scarpina F, Ottonello M, Pistarini C
Neuropsychiatric Disease and Treatment 2023, 19:1321-1329
Published Date: 31 May 2023
Prevalence and Risk Factors of Anxiety Among Adult Patients with Chronic Pharyngitis in Wuhu, China
Zha Z, Gao S, Liu S, Hu G
Neuropsychiatric Disease and Treatment 2023, 19:1313-1319
Published Date: 31 May 2023
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
Heim B, Peball M, Krismer F, Djamshidian A, Seppi K
Neuropsychiatric Disease and Treatment 2023, 19:1303-1312
Published Date: 30 May 2023
Electrocardiogram Abnormalities and Associated Factors Among People with and without Epilepsy Attending the Outpatient Department at Referral Hospitals in Amhara Regional State, Northern Ethiopia, 2022: Institutional-Based Comparative Cross-Sectional Study
Adane T, Melese M, Tesfaye E, Ambelu A, Getnet M, Sinamaw D, Esubalew D, Yismaw Y
Neuropsychiatric Disease and Treatment 2023, 19:1285-1302
Published Date: 30 May 2023
Efficacy of Scalp Acupuncture with the Long-Stay Method on Motor Dysfunction in Patients with Acute Ischemic Stroke: A Randomized Controlled Trial
Wang H, Guo J, Zhang Y, Fang J, Qiu S, He Y, Fan L, Lei X
Neuropsychiatric Disease and Treatment 2023, 19:1273-1283
Published Date: 30 May 2023
The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis
Yue X, Liu XM, Chen J, Chen HY, Tan QQ, Zhou Y
Neuropsychiatric Disease and Treatment 2023, 19:1263-1271
Published Date: 29 May 2023
Exercise-Induced Autophagy Ameliorates Motor Symptoms Progressivity in Parkinson’s Disease Through Alpha-Synuclein Degradation: A Review
Goenawan H, Kiasati S, Sylviana N, Megantara I, Lesmana R
Neuropsychiatric Disease and Treatment 2023, 19:1253-1262
Published Date: 25 May 2023
CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG [Corrigendum]
Simfukwe C, Youn YC, Kim MJ, Paik J, Han SH
Neuropsychiatric Disease and Treatment 2023, 19:1251-1252
Published Date: 24 May 2023
Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
Gagliano A, Carta A, Tanca MG, Sotgiu S
Neuropsychiatric Disease and Treatment 2023, 19:1221-1250
Published Date: 24 May 2023
Network Analysis of ADHD Symptoms and Cognitive Profiles in Children
Zhou Q, Ye X, Wei C, Wu Y, Ren P, Lin X, Li L, Xiang W, Xiao L
Neuropsychiatric Disease and Treatment 2023, 19:1207-1219
Published Date: 18 May 2023
Automatic Thoughts, Self-Stigma, and Resilience Among Schizophrenia Patients with Metabolic Syndrome: A Cross-Sectional Study
Ma S, Ju P, Xia Q, Pan Z, Gao J, Zhang L, Gao H, Yan J, Zhang J, Wang K, Li C, Xie W, Zhu C
Neuropsychiatric Disease and Treatment 2023, 19:1195-1206
Published Date: 17 May 2023
Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
Shrashimirova M, Tyanev I, Cubała WJ, Wichniak A, Vodickova-Borzova C, Ruggieri A, Bonelli A, Lipone P, Comandini A, Cattaneo A
Neuropsychiatric Disease and Treatment 2023, 19:1181-1193
Published Date: 12 May 2023
Clinical Features, Brain-Structure Changes, and Cognitive Impairment in Basal Ganglia Infarcts: A Pilot Study
Zuo L, Dong Y, Hu Y, Xiang X, Liu T, Zhou J, Shi J, Wang Y
Neuropsychiatric Disease and Treatment 2023, 19:1171-1180
Published Date: 11 May 2023
Transcription Factor E2F1 Aggravates Neurological Injury in Ischemic Stroke via microRNA-122-Targeted Sprouty2 [Retraction]
Wu Y, Gao Z, Zhang J
Neuropsychiatric Disease and Treatment 2023, 19:1169-1170
Published Date: 11 May 2023
Psychopathological Dissection of Bipolar Disorder and ADHD: Focussing on Racing Thoughts and Verbal Fluency
Bertschy G, Martz E, Weibel S, Weiner L
Neuropsychiatric Disease and Treatment 2023, 19:1153-1168
Published Date: 11 May 2023
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
Kidambi N, Elsayed OH, El-Mallakh RS
Neuropsychiatric Disease and Treatment 2023, 19:1145-1151
Published Date: 10 May 2023
Comparison of Noninvasive Measurements of Intracranial with Tap Test Results in Patients with Idiopathic Normal Pressure Hydrocephalus
Mendes GAS, Hayashi CY, Vilela GHF, Kido L, Teixeira MJ, Pinto FCG
Neuropsychiatric Disease and Treatment 2023, 19:1127-1143
Published Date: 9 May 2023
Serum Cystatin C is Associated with Depression After Intracerebral Hemorrhage
Zhu L, Yu C, Chang Y, Sun S, Sun Z
Neuropsychiatric Disease and Treatment 2023, 19:1117-1126
Published Date: 8 May 2023
Hemodynamic Changes in Patients with Chronic Internal Carotid Artery Occlusion After Recanalization
Xiao C, Chen X, Lu L, Ye Z, Chen X, Dong M, Qin C
Neuropsychiatric Disease and Treatment 2023, 19:1103-1115
Published Date: 3 May 2023
The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation
Haley CL, Kennard BD, Morris DW, Bernstein IH, Carmody T, Emslie GJ, Mayes TL, Rush AJ
Neuropsychiatric Disease and Treatment 2023, 19:1085-1102
Published Date: 2 May 2023
Acupuncture for Major Depressive Disorder: A Data Mining-Based Literature Study
Tu M, Xiong S, Lv S, Wu X, Hu H, Hu R, Fang J, Shao X
Neuropsychiatric Disease and Treatment 2023, 19:1069-1084
Published Date: 2 May 2023
The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan
Kato M, Tsuda H, Chen Y, Tsuji T, Nishigaki N
Neuropsychiatric Disease and Treatment 2023, 19:1055-1067
Published Date: 1 May 2023
Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis
Wang X, Zhu X, Ji X, Yang J, Zhou J
Neuropsychiatric Disease and Treatment 2023, 19:1043-1053
Published Date: 1 May 2023
Elevated Serum NOX2 Levels Contribute to Delayed Cerebral Ischemia and a Poor Prognosis After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
Wu X, Ji D, Wang Z, Yu W, Du Q, Hu W, Zheng Y, Dong X, Chen F
Neuropsychiatric Disease and Treatment 2023, 19:1027-1042
Published Date: 29 April 2023
Effect of Repeated Intranasal Administration of Different Doses of Insulin on Postoperative Delirium, Serum τ and Aβ Protein in Elderly Patients Undergoing Radical Esophageal Cancer Surgery
Huang Q, Shi Q, Yi X, Zeng J, Dai X, Lin L, Yang Y, Wu X, Gong G
Neuropsychiatric Disease and Treatment 2023, 19:1017-1026
Published Date: 28 April 2023
Frequency and Risk Factors of Subsyndromal Delirium in the Intensive Care Units: A Prospective Cohort Study
Gao Y, Gong S, Zhou W, Li X, Gan X
Neuropsychiatric Disease and Treatment 2023, 19:1003-1016
Published Date: 28 April 2023
Bibliometric Analysis of Research Themes and Trends of the Co-Occurrence of Autism and ADHD
Liu A, Lu Y, Gong C, Sun J, Wang B, Jiang Z
Neuropsychiatric Disease and Treatment 2023, 19:985-1002
Published Date: 24 April 2023
Diagnosis of Epilepsy by Traditional Healers and Its Implications on Management in the Selected Rural Communities of Limpopo and Mpumalanga Provinces: A Qualitative Study
Nemathaga M, Maputle MS, Makhado L, Mashau NS
Neuropsychiatric Disease and Treatment 2023, 19:973-983
Published Date: 18 April 2023
Acupuncture Ameliorated Behavioral Abnormalities in the Autism Rat Model via Pathways for Hippocampal Serotonin
Chen S, Huang L, Liu G, Kang J, Qian Q, Wang J, Wang R, Zheng L, Wang H, Ou P
Neuropsychiatric Disease and Treatment 2023, 19:951-972
Published Date: 18 April 2023
Associations Between Internet Addiction, Psychiatric Comorbidity, and Maternal Depression and Anxiety: Potential Underlying Mechanisms [Response to Letter]
Sakamoto S, Miyawaki D, Goto A, Hirai K, Hama H, Kadono S, Nishiura S, Inoue K
Neuropsychiatric Disease and Treatment 2023, 19:949-950
Published Date: 18 April 2023
Oxytocin and Women Postpartum Depression: A Systematic Review of Randomized Controlled Trials
Zhu J, Jin J, Tang J
Neuropsychiatric Disease and Treatment 2023, 19:939-947
Published Date: 18 April 2023
Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
Wang Z, Zheng Y, Fan Y, Fan Y, Su X, Wang B, Li J, Chen D, Sun F, Li S, Ma J, Li X, Bai L, Li R
Neuropsychiatric Disease and Treatment 2023, 19:929-938
Published Date: 17 April 2023
Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
Yasui-Furukori N, Kawamata Y, Sasaki T, Yokoyama S, Okayasu H, Shinozaki M, Takeuchi Y, Sato A, Ishikawa T, Komahashi-Sasaki H, Miyazaki K, Fukasawa T, Furukori H, Sugawara N, Shimoda K
Neuropsychiatric Disease and Treatment 2023, 19:921-928
Published Date: 17 April 2023
Transcutaneous Electrical Acupoint Stimulation for Preventing Postoperative Delirium: A Meta-Analysis
Guo F, Yan Y, Sun L, Han R, Zheng L, Qin Y, Wang S, Sun X, Ji Z, Gao C
Neuropsychiatric Disease and Treatment 2023, 19:907-920
Published Date: 15 April 2023
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
Giron‐Hernandez C, Han JH, Alberio R, Singh A, García-Portilla MP, Pompili M, Knight RK, Richarz U, Gopal S, Antunes J
Neuropsychiatric Disease and Treatment 2023, 19:895-906
Published Date: 13 April 2023
Nomogram-Based Prediction of the Futile Recanalization Risk Among Acute Ischemic Stroke Patients Before and After Endovascular Therapy: A Retrospective Study
Guan J, Wang Q, Hu J, Hu Y, Lan Q, Xiao G, Zhou B, Guan H
Neuropsychiatric Disease and Treatment 2023, 19:879-894
Published Date: 13 April 2023
Garden Cress (Lepidium sativum) Seeds Ameliorated Aluminum-Induced Alzheimer Disease in Rats Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects
Balgoon MJ
Neuropsychiatric Disease and Treatment 2023, 19:865-878
Published Date: 12 April 2023
CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG
Simfukwe C, Youn YC, Kim MJ, Paik J, Han SH
Neuropsychiatric Disease and Treatment 2023, 19:851-863
Published Date: 12 April 2023
Pathology and Astrocytes in Autism
Vakilzadeh G, Martinez-Cerdeño V
Neuropsychiatric Disease and Treatment 2023, 19:841-850
Published Date: 12 April 2023
Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
Zhu Y, Wu Z, Zhao D, Wu X, He R, Wang Z, Peng D, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:829-839
Published Date: 12 April 2023
Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
Kanes SJ, Dennie L, Perera P
Neuropsychiatric Disease and Treatment 2023, 19:811-828
Published Date: 12 April 2023
Correlation Between Aggressive Behavior and Impulsive and Aggressive Personality Traits in Stable Patients with Schizophrenia
Gao L, Yang R, Fan HZ, Wang LL, Zhao YL, Tan SP, Xiao CL, Zhou SJ
Neuropsychiatric Disease and Treatment 2023, 19:801-809
Published Date: 12 April 2023
Vitamin B12, Folate, Homocysteine, Inflammatory Mediators (Interleukin-6, Tumor Necrosis Factor-α and C-Reactive Protein) Levels in Adolescents with Anxiety or Depressive Symptoms
Tan Y, Zhou L, Huang J, Chen X, Wu Y, Song X, Wang J, Hu H, Yang Q
Neuropsychiatric Disease and Treatment 2023, 19:785-800
Published Date: 7 April 2023
Recombinant Adenovirus-Mediated HIF-lα Ameliorates Neurological Dysfunction by Improving Energy Metabolism in Ischemic Penumbra After Cerebral Ischemia-Reperfusion in Rats
Zhou W, Tao T, Yu W, Wu W, Hui Z, Xu H, Li Y, Zhang Y, Yang X
Neuropsychiatric Disease and Treatment 2023, 19:775-784
Published Date: 6 April 2023
Associations Between Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Traits and Sociodemographic Characteristics in Japanese Workers
Suzuki T, Wada K, Nakazato M, Ohtani T, Yamazaki M, Ikeda S
Neuropsychiatric Disease and Treatment 2023, 19:759-773
Published Date: 5 April 2023
Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
Zhao M, Qin B, Mao Y, Zhang Y, Zhao R, Wang A, Wang H, Zhao J, Wang C
Neuropsychiatric Disease and Treatment 2023, 19:749-757
Published Date: 5 April 2023
Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions
Singh A, Hadjinicolaou A, Peters JM, Salussolia CL
Neuropsychiatric Disease and Treatment 2023, 19:733-748
Published Date: 5 April 2023
Use of Selective Alternative Therapies for Treatment of OCD
Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A
Neuropsychiatric Disease and Treatment 2023, 19:721-732
Published Date: 5 April 2023
The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy
Peng Q, Chen W, E Y, Deng Y, Xu Z, Wang S, Fu X, Wei B, Wang M, Hou J, Zhang Y, Duan R
Neuropsychiatric Disease and Treatment 2023, 19:709-719
Published Date: 4 April 2023
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
Chen X, Hou X, Bai D, Lane R, Zhang C, Canuso C, Wang G, Fu DJ
Neuropsychiatric Disease and Treatment 2023, 19:693-707
Published Date: 31 March 2023
Associations Between Internet Addiction, Psychiatric Comorbidity, and Maternal Depression and Anxiety: Potential Underlying Mechanisms [Letter]
Teixeira Filho A, Xavier de Almeida A
Neuropsychiatric Disease and Treatment 2023, 19:689-691
Published Date: 29 March 2023
Neurocognitive Impairment and Associated Factors Among People Living with HIV: A Systematic Review and Meta-Analysis of African Studies
Zenebe Y, Akele B, W/Selassie M, Necho M
Neuropsychiatric Disease and Treatment 2023, 19:673-687
Published Date: 28 March 2023
Effects of Psychiatric Disease Severity and Clinical Characteristics on Duration of High Violence Risk: A Perspective on Violence Prevention in the Psychiatric Ward
Chang PY, Chen JH, Cheng HW, Wang YC
Neuropsychiatric Disease and Treatment 2023, 19:663-671
Published Date: 27 March 2023
Appropriate Outcome Choice Requires Certainty About Symptom Patterns of Patient Subgroups – We are Still Left with Unexplained Heterogeneity [Response To Letter]
Simon MS
Neuropsychiatric Disease and Treatment 2023, 19:661-662
Published Date: 27 March 2023
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
Hort J, Duning T, Hoerr R
Neuropsychiatric Disease and Treatment 2023, 19:647-660
Published Date: 23 March 2023
Plasma Lipoprotein-Associated Phospholipase A2 Affects Cognitive Impairment in Patients with Cerebral Microbleeds
Liu L, Zhang X, Jiang N, Liu Y, Wang Q, Jiang G, Li X, Zhao L, Zhai Q
Neuropsychiatric Disease and Treatment 2023, 19:635-646
Published Date: 22 March 2023
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
Haider B, O'Sullivan AK, Bessonova L, Keane E, Achtyes E, Harvey PD, Kane JM, Saklad SR, Trotter JP, Claxton A, Polak T, McGrory J, Noori W, Sikora Kessler A, Yarlas A, Velligan D
Neuropsychiatric Disease and Treatment 2023, 19:623-634
Published Date: 17 March 2023
Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study
Matsuzaki H, Hatano M, Iwata M, Saito T, Yamada S
Neuropsychiatric Disease and Treatment 2023, 19:615-622
Published Date: 15 March 2023
Research Hotspots and Global Trends of Transcranial Direct Current Stimulation in Stroke: A Bibliometric Analysis
Zhou K, Zhou Y, Zeng Y, Zhang J, Cai X, Qin J, Li Z, Yan F
Neuropsychiatric Disease and Treatment 2023, 19:601-613
Published Date: 15 March 2023
Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis
Chen CC, Zhou N, Hu N, Feng JG, Wang XB
Neuropsychiatric Disease and Treatment 2023, 19:587-599
Published Date: 14 March 2023
Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia
Miljevic C, Munjiza-Jovanovic A, Jovanovic T
Neuropsychiatric Disease and Treatment 2023, 19:579-586
Published Date: 11 March 2023
A Systematic Review Assessing Patient-Related Predictors of Response to Transcranial Magnetic Stimulation in Major Depressive Disorder
Gonterman F
Neuropsychiatric Disease and Treatment 2023, 19:565-577
Published Date: 8 March 2023
Serum TSH Levels are Associated with Hyperactivity Behaviors in Children with Attention Deficit/Hyperactivity Disorder
Chen G, Gao W, Xu Y, Chen H, Cai H
Neuropsychiatric Disease and Treatment 2023, 19:557-564
Published Date: 7 March 2023
The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders
Zhu Y, Wu L, Ye S, Fu Y, Huang H, Lai J, Shi C, Hu S
Neuropsychiatric Disease and Treatment 2023, 19:547-556
Published Date: 7 March 2023
The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia
Milz R, Benson C, Knight K, Antunes J, Najarian D, Lopez Rengel PM, Wang S, Richarz U, Gopal S, Kane JM
Neuropsychiatric Disease and Treatment 2023, 19:531-545
Published Date: 7 March 2023
Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs
Bramante S, Di Salvo G, Maina G, Rosso G
Neuropsychiatric Disease and Treatment 2023, 19:519-530
Published Date: 7 March 2023
Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
Wessa C, Morrens M, De Picker LJ
Neuropsychiatric Disease and Treatment 2023, 19:515-517
Published Date: 4 March 2023
Resilience and Quality of Life in People with Mental Illness: A Systematic Review and Meta-Analysis
Chuang SP, Wu JYW, Wang CS
Neuropsychiatric Disease and Treatment 2023, 19:507-514
Published Date: 4 March 2023
Validation of the Spanish Version of the Trauma and Loss Spectrum Self-Report (TALS-SR): A Study on Healthcare Workers Facing the COVID-19 Pandemic
Carmassi C, Pedrinelli V, Antonini C, Dell'Oste V, Gravina D, Nardi B, Bertelloni CA, Massimetti G, Nieto-Munuera J, Dell'Osso L
Neuropsychiatric Disease and Treatment 2023, 19:495-506
Published Date: 3 March 2023
Gender Dysphoria: Optimizing Healthcare for Transgender and Gender Diverse Youth with a Multidisciplinary Approach
Coyne CA, Yuodsnukis BT, Chen D
Neuropsychiatric Disease and Treatment 2023, 19:479-493
Published Date: 28 February 2023
Prevalence of Posttraumatic Stress Disorder and Depression Among Internally Displaced Persons in Mogadishu-Somalia
Ali M, Mutavi T, Mburu JM, Mathai M
Neuropsychiatric Disease and Treatment 2023, 19:469-478
Published Date: 28 February 2023
Literature Overview of the Relation Between Psoriasis and Alzheimer
Yang Q, Wang J, Mi N, Zou Y
Neuropsychiatric Disease and Treatment 2023, 19:461-468
Published Date: 28 February 2023
Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study
Bai L, Liang W, Wang Y, Fan N, zhang Q, Bian Y, Yang F
Neuropsychiatric Disease and Treatment 2023, 19:453-460
Published Date: 27 February 2023
Validation of the THINC-It Tool for Assessment of Cognitive Impairment in Patients with Bipolar Depression
Zhu N, Zhang W, Huang J, Su Y, Lu J, Yang L, Shi Y, Hu S, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:443-452
Published Date: 27 February 2023
Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
Young AH, Abdelghani M, Juruena MF, Nikolova VL, Nilforooshan R
Neuropsychiatric Disease and Treatment 2023, 19:433-441
Published Date: 24 February 2023
Perinatal Mental Health Disorders: A Review of Lessons Learned from Obstetric Care Settings
Ayala NK, Lewkowitz AK, Whelan AR, Miller ES
Neuropsychiatric Disease and Treatment 2023, 19:427-432
Published Date: 23 February 2023
Combining Multiple Indices of Diffusion Tensor Imaging Can Better Differentiate Patients with Traumatic Brain Injury from Healthy Subjects [Corrigendum]
Abdelrahman HAF, Ubukata S, Ueda K, Fujimoto G, Oishi N, Aso T, Murai T
Neuropsychiatric Disease and Treatment 2023, 19:425-426
Published Date: 23 February 2023
Systematic Review on EEG Analysis to Diagnose and Treat Autism by Evaluating Functional Connectivity and Spectral Power
Bogéa Ribeiro L, da Silva Filho M
Neuropsychiatric Disease and Treatment 2023, 19:415-424
Published Date: 22 February 2023
Systemic Immune-Inflammation Index is Associated with Cerebral Small Vessel Disease Burden and Cognitive Impairment
Xiao Y, Teng Z, Xu J, Qi Q, Guan T, Jiang X, Chen H, Xie X, Dong Y, Lv P
Neuropsychiatric Disease and Treatment 2023, 19:403-413
Published Date: 21 February 2023
Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
Root S, Ahn K, Kirsch J, Hoskin JL
Neuropsychiatric Disease and Treatment 2023, 19:391-401
Published Date: 20 February 2023
Prevalence and Influence Factors for Non-Alcoholic Fatty Liver Disease in Long-Term Hospitalized Patients with Schizophrenia: A Cross-Sectional Retrospective Study
Li X, Gao Y, Wang Y, Wang Y, Wu Q
Neuropsychiatric Disease and Treatment 2023, 19:379-389
Published Date: 18 February 2023
Exploration of the Risk Factors of Anemia in Patients with Tuberculous Meningitis in South China
Wen A, Leng EL, Cao WF, Xiang ZB, Rao W, Cai W, Zhou YL, Hu F, Wu LF, Zhang P, Liu SM
Neuropsychiatric Disease and Treatment 2023, 19:369-377
Published Date: 16 February 2023
Altered Functional Activity and Functional Connectivity of Seed Regions Based on ALFF Following Acupuncture Treatment in Patients with Stroke Sequelae with Unilateral Limb Numbness [Corrigendum]
Peng J, Su J, Song L, Lv Q, Gao Y, Chang J, Zhang H, Zou Y, Chen X
Neuropsychiatric Disease and Treatment 2023, 19:367-368
Published Date: 14 February 2023
Cognitive Impairment Mechanism in Patients with Bipolar Disorder
Huang Y, Zhang Z, Lin S, Zhou H, Xu G
Neuropsychiatric Disease and Treatment 2023, 19:361-366
Published Date: 10 February 2023
Environmental Factors in the Etiology of Mental Disorders in the Czech Republic
Hosak L, Hosakova K, Malekirad M, Kamaradova Koncelikova D, Zapletalova J, Latalova K
Neuropsychiatric Disease and Treatment 2023, 19:349-359
Published Date: 7 February 2023
Erroneous Thought in Inpatients with Major Depressive Disorder: The Role of Psychological Trauma During Childhood and Adulthood
Chiu CD, Chou LS, Hsieh YC, Lin CH, Li DJ
Neuropsychiatric Disease and Treatment 2023, 19:337-348
Published Date: 5 February 2023
Correlation Between Rats Hippocampal ATP Content and Delayed Encephalopathy After Acute Carbon Monoxide Poisoning
Gao H, Chen C, Zhao X, Zhao L, Zheng X, Sun H, Bao H, Wang B
Neuropsychiatric Disease and Treatment 2023, 19:329-336
Published Date: 5 February 2023
A Novel Metabolic Score for Insulin Resistance and Symptomatic Intracranial Hemorrhage in Ischemic Stroke Patients After Endovascular Thrombectomy
Chen S, E Y, Zhang X, Wei B, Wang S, Xu Z, Gong P, Xie Y, Qin C, Zhang Y
Neuropsychiatric Disease and Treatment 2023, 19:321-328
Published Date: 5 February 2023
Neurological Manifestations of Long COVID: A Single-Center One-Year Experience
Taruffi L, Muccioli L, Mitolo M, Ferri L, Descovich C, Mazzoni S, Michelucci R, Lodi R, Liguori R, Cortelli P, Tonon C, Bisulli F
Neuropsychiatric Disease and Treatment 2023, 19:311-319
Published Date: 3 February 2023
Subclinical Hypothyroidism is Associated with Cognitive Impairment in Patients with Cerebral Small Vessel Disease
Teng Z, Feng J, Lv P
Neuropsychiatric Disease and Treatment 2023, 19:303-310
Published Date: 3 February 2023
Association Between Single Nucleotide Polymorphisms Within lncRNA NONHSAT102891 and Depression Susceptibility in a Chinese Population
Liang P, Sun Y, Li Y, Liang Y
Neuropsychiatric Disease and Treatment 2023, 19:293-302
Published Date: 2 February 2023
Correlations Between Serum CXCL9/12 and the Severity of Acute Ischemic Stroke, a Retrospective Observational Study
Han M, Ma B, She R, Xing Y, Li X
Neuropsychiatric Disease and Treatment 2023, 19:283-292
Published Date: 29 January 2023
Trajectories of Efficacy and Cognitive Function During Electroconvulsive Therapy Course in Young Adults with Treatment-Resistant Depression
Xu S, Xie X, Yao L, Chen L, Wan Q, Chen Z, Liu Z
Neuropsychiatric Disease and Treatment 2023, 19:267-281
Published Date: 29 January 2023
Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs
Masood N, Jimenez-Shahed J
Neuropsychiatric Disease and Treatment 2023, 19:247-266
Published Date: 25 January 2023
Altered Functional Activity and Functional Connectivity of Seed Regions Based on ALFF Following Acupuncture Treatment in Patients with Stroke Sequelae with Unilateral Limb Numbness
Peng J, Su J, Song L, Lv Q, Gao Y, Chang J, Zhang H, Zou Y, Chen X
Neuropsychiatric Disease and Treatment 2023, 19:233-245
Published Date: 25 January 2023
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
Litman R, Naber D, Anta L, Martínez J, Filts Y, Correll CU
Neuropsychiatric Disease and Treatment 2023, 19:219-232
Published Date: 25 January 2023
Correlation Between Cognitive Impairment and Homocysteine and S100B Protein in Patients with Progressive Ischemic Stroke
Li Y, Chen X, Zhou R, Xu W, Wang X, Chao W, Xue S
Neuropsychiatric Disease and Treatment 2023, 19:209-217
Published Date: 21 January 2023
Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
Rodríguez-Ramírez AM, Alcántara-Garcés MT, Hernández-Jiménez S, García-Ulloa AC, Arcila-Martínez D, Velázquez-Jurado H, Arizmendi-Rodríguez RE
Neuropsychiatric Disease and Treatment 2023, 19:197-207
Published Date: 23 January 2023
Impact of Childhood Trauma and Adult Separation Anxiety Disorder on Quality of Life in Individuals with Schizophrenia
Karaytuğ MO, Tamam L, Demirkol ME, Namlı Z, Gürbüz M, Yeşiloğlu C
Neuropsychiatric Disease and Treatment 2023, 19:181-196
Published Date: 23 January 2023
Nursing Students Facilitating the Transition from Suicidal Ideation to Action in the Rural: A Qualitative Study
Yunitasari E, Yusuf A, Aditya RS, Acob JRU, Solikhah FK, Alrazeeni DM
Neuropsychiatric Disease and Treatment 2023, 19:171-180
Published Date: 19 January 2023
Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
Zhang H, Lv QW, Zheng ZQ, Shen LJ, Zhou J, Guo M
Neuropsychiatric Disease and Treatment 2023, 19:153-169
Published Date: 18 January 2023
Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article
Matutino Santos P, Pereira Campos G, Nascimento C
Neuropsychiatric Disease and Treatment 2023, 19:133-151
Published Date: 14 January 2023
The Neural Correlates of the Recognition of Emotional Intensity Deficits in Major Depression: An ERP Study
Li M, Zhang J, Jiang C, Wang J, Sun R, Jin S, Zhang N, Zhou Z
Neuropsychiatric Disease and Treatment 2023, 19:117-131
Published Date: 12 January 2023
Add-On Intermittent Theta Burst Stimulation Improves the Efficacy of First-Episode and Recurrent Major Depressive Disorder: Real-World Clinical Practice
Li G, Lei L, Yang C, Liu Z, Zhang KR
Neuropsychiatric Disease and Treatment 2023, 19:109-116
Published Date: 13 January 2023
Glutathione S-Transferase M1/T1 Polymorphisms and Schizophrenia Risk: A New Method for Quality Assessment and a Systematic Review
Liu H, Xu Y, Peng J
Neuropsychiatric Disease and Treatment 2023, 19:97-107
Published Date: 7 January 2023
Relapse After Drug Withdrawal in Patients with Epilepsy After Two Years of Seizure-Free: A Cohort Study
Zhang X, Zeng J, Gu X, Zhang F, Han Y, Zhang P, Wang Q, Gu R
Neuropsychiatric Disease and Treatment 2023, 19:85-95
Published Date: 6 January 2023
Wistar Rats Hippocampal Neurons Response to Blood Low-Density Polyethylene Microplastics: A Pathway Analysis of SOD, CAT, MDA, 8-OHdG Expression in Hippocampal Neurons and Blood Serum Aβ42 Levels
Sincihu Y, Lusno MFD, Mulyasari TM, Elias SM, Sudiana IK, Kusumastuti K, Sulistyorini L, Keman S
Neuropsychiatric Disease and Treatment 2023, 19:73-83
Published Date: 5 January 2023
Psychological Resilience and Stress Coping Styles in Migraine Patients
Kurtses Gürsoy B, Köseoğlu Toksoy C
Neuropsychiatric Disease and Treatment 2023, 19:63-72
Published Date: 5 January 2023
Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
Zhang P, Wang T, Zhu X, Feng L, Wang J, Li Y, Zhang X, Cui T, Li M
Neuropsychiatric Disease and Treatment 2023, 19:49-62
Published Date: 4 January 2023
Quality of the Evidence Supporting the Role of Acupuncture Interventions for Vascular Dementia
Shi H, Zhang X, Si G, Jia H
Neuropsychiatric Disease and Treatment 2023, 19:27-48
Published Date: 4 January 2023
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
Simon MS, Arteaga-Henríquez G, Fouad Algendy A, Siepmann T, Illigens BMW
Neuropsychiatric Disease and Treatment 2023, 19:1-25
Published Date: 5 January 2023